CCA
NAMSW icon

Castle Creek Arbitrage’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Castle Creek Arbitrage’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-51,520
Closed -$43K – 468
2022
Q4 		$43K Buy
+51,520
New +$42.4K ﹤0.01% 288

Other funds holding NAMSW

Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Westchester Capital Management (New York)
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Castle Creek Arbitrage's NAMSW Position: Q1 2023 in Review

Castle Creek Arbitrage sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q1 2023, closing a stake of 51,520 shares — an estimated $43K sold.

Castle Creek Arbitrage first reported a position in NAMSW in Q4 2022 and held it in 1 quarter. The position peaked at $43K in Q4 2022. 18 funds tracked by Wall St. Rank hold NAMSW as of Q1 2023.

  • Castle Creek Arbitrage reported no remaining NewAmsterdam Pharma Warrant position as of Q1 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 51,520 NewAmsterdam Pharma Warrant shares in Q1 2023, an estimated $43K.
  • Castle Creek Arbitrage first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and held it in 1 quarter.
  • Castle Creek Arbitrage's NewAmsterdam Pharma Warrant position peaked at $43K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2023.

Based on Castle Creek Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.